Streptokinase induced primary intraventricular haemorrhage

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Thrombolytic therapy is a cornerstone treatment for acute myocardial infarction.
• Intraventricular hemorrhage is a serious but rare complication of anticoagulant and thrombolytic therapies.
• Primary intraventricular hemorrhage directly within the ventricles without a preceding parenchymal bleed is exceptionally uncommon.

Purpose of the Study:

• To report a case of primary intraventricular hemorrhage occurring secondary to thrombolytic therapy.
• To discuss the potential association between streptokinase, heparinization, and intraventricular bleeding.
• To highlight the clinical presentation and recovery course of this rare complication.

Main Methods:

• A case study of a 55-year-old male patient with acute myocardial infarction.
• Administration of intravenous streptokinase followed by heparinization.
• Monitoring for neurological complications and assessment of hemorrhage via imaging (implied).

Main Results:

• The patient developed an extensive primary intraventricular hemorrhage.
• The hemorrhage occurred secondary to the prescribed thrombolytic therapy and anticoagulation.
• The patient experienced an uneventful recovery over a three-month period.

Conclusions:

• Primary intraventricular hemorrhage can be a rare complication of thrombolytic therapy, even without prior brain injury.
• This case underscores the importance of vigilance for neurological events in patients receiving thrombolytics and anticoagulants.
• Despite the severity, uneventful recovery is possible with appropriate management.